Efficacy of Futibatinib, an Irreversible Fibroblast Growth Factor Receptor Inhibitor, in FGFR-Altered Breast Cancer

The authors elucidated the efficacy of futibatinib in breast cancer and identified the molecular features associated with its antitumor activity.